Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Alzheimer’s Therapy Market: By Drug Class, By Distribution Channel, and Geography
Alzheimer’s Therapy market size was valued at US$ 4,211.8 million in 2022 and is poised to grow at a CAGR of 16.3% from 2023 to 2029. Alzheimer’s disease is a neurological disorder that causes the brain to shrink and brain cells to die. Alzheimer’s disease is the most common cause of dementia that leads to continuous decline in thought process, social and behavioural skills that affect the ability of a person to function independently. The early symptoms of Alzheimer’s disease include forgetting recent events or conversations. An Alzheimer diseased patient portal will have a severe memory loss and lose the ability to carry out everyday tasks as the disease progresses. The rise in prevalence of Alzheimer’s disease in emerging countries and developed countries is expected to drive the market growth in the forecasted period. In addition, the increase in occurrence of Alzheimer’s disease across the globe by the diagnosis of patients has boosted the Alzheimer’s disease therapy. According to Alzheimer’s Association, approximately 6 million people are living with Alzheimer’s in USA and it can be expected to reach 13 Million by 2050. Moreover, availability of various drug class for Alzheimer’s disease is expected to boost to growth of Alzheimer’s disease market. The increase in number of Alzheimer disease cases thus increases the demand for Alzheimer’s therapy. Advancement in the treatment, and drug discovery techniques drives the demand for Alzheimer’s therapy across the globe. Rising investment in research and development of innovative drugs by the key pharmaceutical companies is expected to fuel the growth Alzheimer’s disease market. In addition, the presence of pipeline drugs in the clinical trial phase is expected to boost the growth of Alzheimer’s market in a significant rate in the forecasted period. Geographically, North America region held the major market share in 2022 and is expected to dominate the global Alzheimer’s therapy market in the forecasted years.
Alzheimer’s Therapy Market Key Developments:
Study Period
2024-2030Base Year
2023CAGR
16.3%Largest Market
North AmericaFastest Growing Market
Asia Pacific
Alzheimer’s therapy market is expected to grow due to the increasing prevalence of Alzheimer’s disease across the globe. Advancement of technology and innovation of new drugs is expected to drive the growth of Alzheimer’s disease market. Availability of various drug class for Alzheimer’s disease, presence of several pipeline drugs in the clinical trial phase is expected to fuel the growth of Alzheimer’s therapy market. The rising investment in the research and development of new drugs by the key pharmaceutical companies is expected to propel the market growth at a significant in the forecasted period.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 4,211.8 million |
Market CAGR |
16.3% |
By Drug Class |
|
By Distribution Channel |
|
By Region |
|
Download Free Sample Report
Alzheimer’s Therapy market was valued at US$ 4,211.8 million in 2022 and is expected to grow at a 16.3% CAGR from 2023 to 2029
The discontinuation of Alzheimer’s therapy due to the lack of efficacy and lack of improvement in cognitive function is expected to restrain the growth of Alzheimer’s therapy market.
The leading players in the global Alzheimer’s Therapy market are Eisai Co., Ltd., Novartis AG., AbbVie Inc., Adamas Pharmaceuticals, Inc., H. Lundbeck A/S., Biogen, AC Immune., Cyclo Therapeutics Inc., F. Hoffmann La Roche Ltd., Daiichi Sankyo Company, Limited., Johnson & Johnson Services, Inc., TauRx Pharmaceuticals Ltd.
1. Executive Summary |
2. Global Alzheimer’s Therapy Market Introduction |
2.1.Global Alzheimer’s Therapy Market - Taxonomy |
2.2.Global Alzheimer’s Therapy Market - Definitions |
2.2.1.Drug Class |
2.2.2.Distribution Channel |
2.2.3.Region |
3. Global Alzheimer’s Therapy Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Alzheimer’s Therapy Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Alzheimer’s Therapy Market By Drug Class, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Cholinesterase Inhibitors |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. N-Methyl D-Aspartate Antagonist |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Combination Drugs |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Others |
5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Alzheimer’s Therapy Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Hospital Pharmacy |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Retail Pharmacy |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Online Pharmacy |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Alzheimer’s Therapy Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia Pacific (APAC) |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Middle East and Africa (MEA) |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Latin America |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. North America Alzheimer’s Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Drug Class Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.1.1.Cholinesterase Inhibitors |
8.1.2.N-Methyl D-Aspartate Antagonist |
8.1.3.Combination Drugs |
8.1.4.Others |
8.2. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.2.1.Hospital Pharmacy |
8.2.2.Retail Pharmacy |
8.2.3.Online Pharmacy |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
8.3.1.United States of America (USA) |
8.3.2.Canada |
9. Europe Alzheimer’s Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cholinesterase Inhibitors |
9.1.2.N-Methyl D-Aspartate Antagonist |
9.1.3.Combination Drugs |
9.1.4.Others |
9.2. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Hospital Pharmacy |
9.2.2.Retail Pharmacy |
9.2.3.Online Pharmacy |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Germany |
9.3.2.France |
9.3.3.Italy |
9.3.4.United Kingdom (UK) |
9.3.5.Spain |
9.3.6.Rest of EU |
10. Asia Pacific (APAC) Alzheimer’s Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cholinesterase Inhibitors |
10.1.2.N-Methyl D-Aspartate Antagonist |
10.1.3.Combination Drugs |
10.1.4.Others |
10.2. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Hospital Pharmacy |
10.2.2.Retail Pharmacy |
10.2.3.Online Pharmacy |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.China |
10.3.2.India |
10.3.3.Australia and New Zealand (ANZ) |
10.3.4.Japan |
10.3.5.Rest of APAC |
11. Middle East and Africa (MEA) Alzheimer’s Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cholinesterase Inhibitors |
11.1.2.N-Methyl D-Aspartate Antagonist |
11.1.3.Combination Drugs |
11.1.4.Others |
11.2. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Hospital Pharmacy |
11.2.2.Retail Pharmacy |
11.2.3.Online Pharmacy |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.GCC Countries |
11.3.2.South Africa |
11.3.3.Rest of MEA |
12. Latin America Alzheimer’s Therapy Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Drug Class Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cholinesterase Inhibitors |
12.1.2.N-Methyl D-Aspartate Antagonist |
12.1.3.Combination Drugs |
12.1.4.Others |
12.2. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Hospital Pharmacy |
12.2.2.Retail Pharmacy |
12.2.3.Online Pharmacy |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Brazil |
12.3.2.Mexico |
12.3.3.Rest of LA |
13. Competition Landscape |
13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
13.2.1.Eisai Co., Ltd. |
13.2.2.Novartis AG. |
13.2.3.AbbVie Inc. |
13.2.4.Adamas Pharmaceuticals, Inc. |
13.2.5.H. Lundbeck A/S. |
13.2.6.Biogen. |
14. Research Methodology |
15. Appendix and Abbreviations |
Key Market Players